Showing 641 - 660 results of 43,595 for search '(( 50 ((nn decrease) OR (mean decrease)) ) OR ( 5 ((we decrease) OR (teer decrease)) ))', query time: 0.84s Refine Results
  1. 641
  2. 642

    Data Sheet 1_Probiotic Limosilactobacillus reuteri KUB-AC5 decreases urothelial cell invasion and enhances macrophage killing of uropathogenic Escherichia coli in vitro study.pdf by Arishabhas Tantibhadrasapa (13929639)

    Published 2024
    “…However, the antibacterial and immune modulatory effects of AC5 on UPEC have never been explored.</p>Methods<p>Here, we investigated both the direct and indirect effects of AC5 against UPEC isolates (UTI89, CFT073, and clinical MDR UPEC AT31) in vitro. …”
  3. 643

    Table_5_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx by Xiao-yang Gong (13103400)

    Published 2022
    “…A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”
  4. 644
  5. 645
  6. 646
  7. 647
  8. 648

    Tetrahydrohyperforin Inhibits the Proteolytic Processing of Amyloid Precursor Protein and Enhances Its Degradation by Atg5-Dependent Autophagy by Viviana A. Cavieres (500139)

    Published 2015
    “…To investigate the contribution of autophagy, we tested the effect of IDN5706 in Atg5-depleted cells. …”
  9. 649
  10. 650

    DataSheet_1_Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma.pdf by Juan José Nieto-Fontarigo (11800142)

    Published 2021
    “…Background<p>Both anti-viral and anti-inflammatory bronchial effects are warranted to treat viral infections in asthma. We sought to investigate if imiquimod, a TLR7 agonist, exhibits such dual actions in ex vivo cultured human bronchial epithelial cells (HBECs), targets for SARS-CoV-2 infectivity.…”
  11. 651
  12. 652
  13. 653
  14. 654
  15. 655
  16. 656

    Fig 7 - by C. Vijay Reena Durai (14498259)

    Published 2023
    Subjects:
  17. 657
  18. 658
  19. 659

    Fig 1 - by C. Vijay Reena Durai (14498259)

    Published 2023
    Subjects:
  20. 660